单侧头颈原发不明癌术后放疗靶区范围对结局的影响
该回顾性研究比较单侧头颈原发不明癌(HNCUP)术后单侧颈部放疗(UL-RT)与双侧颈部加全黏膜放疗(COMP-RT)的结局。中位随访6.3年,两组原发肿瘤出现率、颈部淋巴结复发率和总生存均无显著差异,UL-RT组生活质量有改善趋势。
要点
- 单侧HNCUP术后UL-RT与COMP-RT在原发肿瘤出现率、颈部复发率和总生存上无显著差异。
- UL-RT组生活质量较COMP-RT组有改善趋势。
- UL-RT或可作为单侧HNCUP术后放疗的相似结局选择。
核心结论
- 在单侧HNCUP管理中,UL-RT似乎提供与COMP-RT相似的肿瘤学结局。
研究设计与样本
- 23例接受UL-RT,46例接受COMP-RT,评估肿瘤学结局及长期生活质量。
主要发现
- 中位随访6.3年,UL-RT与COMP-RT组原发肿瘤出现率无显著差异(P = .68)。
- 两组颈部淋巴结复发率无显著差异(P = .34)。
- 两组总生存无显著差异(P = .33)。
- UL-RT组观察到生活质量改善趋势。
临床怎么用
- 对于经PET-CT和全内镜检查确认无原发灶的单侧HNCUP,术后可考虑UL-RT以可能改善生活质量而不影响肿瘤学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We compared the outcome of postoperative unilateral cervical nodes radiotherapy (UL-RT) vs bilateral cervical nodes plus total mucosal irradiation (COMP-RT) in the management of head and neck carcinoma of unknown primary (HNCUP). METHODS: HNCUP, defined by the absence of primary despite a PET-CT combined with a panendoscopy, were treated with curative intent by initial ipsilateral neck dissection. Sixty-nine patients with unilateral HNCUP were included: 23 received UL-RT while 46 received COMP-RT. Carcinologic outcomes and long-term quality of life (QOL) according to the QOL Questionnaire for Head and Neck 35 were assessed. RESULTS: Within 6.3 years of median follow-up, there was no significant difference in primary tumor emergence rate (P = .68), cervical node recurrence rate (P = .34), or overall survival (P = .33) between UL-RT and COMP-RT groups. A trend toward QOL improvement was observed in the UL-RT group. CONCLUSION: UL-RT seems to provide similar outcomes as COMP-RT in unilateral HNCUP management.
引用
- Podeur F, Pommier P, Crozes C, et al. Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes. Head Neck. 2019. PMID: 31737971. doi:10.1002/hed.26007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。